Dr. Green has more than 25 years of experience in designing, creating and using transgenic mouse platforms for antibody drug discovery. He is an inventor on several dozen patents including on the AlivaMab Mouse and Amgen's (formerly Abgenix) XenoMouse technology and its improvements that have yielded marketed antibody drugs. He has a Ph.D. in Molecular and Cellular Biology from the University of Wisconsin-Madison and did postdoctoral research at the University of Colorado at Boulder and Stanford University.